Copes v. Delaware Transit Authority ( 2023 )


Menu:
  •       IN THE SUPERIOR COURT OF THE STATE OF DELAWARE
    LA’TISHA COPES,                           )
    )
    Employee-Below, Appellant,          )
    )
    v.                            )     ID No. N22A-05-001 FWW
    )
    DELAWARE TRANSIT AUTHORITY,               )
    )
    Employer-Below, Appellee.           )
    Submitted: November 29, 2022
    Decided: February 2, 2023
    MEMORANDUM OPINION
    On Appeal from the Industrial Accident Board:
    AFFIRMED.
    James J. Haley, Jr., Esquire, FERRARA & HALEY, 1716 Wawaset Street,
    Wilmington, Delaware 19806, Attorney for Appellant La’Tisha Copes.
    John J. Klusman, Esquire, TYBOUT, REDFEARN & PELL, 501 Carr Road, Suite
    300, P.O. Box 2092, Wilmington, Delaware 19809, Attorney for Appellee Delaware
    Transit Authority.
    WHARTON, J.
    I.    INTRODUCTION
    La’Tisha Copes (“Copes”) filed a Notice of Appeal on May 2, 2022 seeking
    a review of the Industrial Accident Board’s (“IAB”) April 4, 2022 decision. Copes
    contends that the IAB erred when it denied her request to continue a merit hearing
    until after she had shoulder/acromioclavicular (“AC”) surgery. She argues that this
    decision was an error because her surgeon’s opinion could not be fully developed
    until after performing the surgery. Her employer, the Delaware Transit Authority
    (“DART”) counters that the IAB properly exercised its discretion to deny the request
    and that its denial should be affirmed.
    The Court must decide whether the IAB’s decision is supported by substantial
    evidence and is free from legal error. Specifically, the Court must determine whether
    the IAB erred as a matter of law when it denied Copes’ continuance request. Since
    the IAB’s decision was a discretionary matter, the Court also must determine
    whether the decision to deny Copes’ request was unreasonable or capricious.
    Upon consideration of the pleadings and the record below, the Court finds that
    the IAB’s decision was supported by substantial evidence, free of legal error, and
    neither unreasonable nor capricious. The IAB’s decision is AFFIRMED.
    \
    1
    II. FACTUAL AND PROCEDURAL CONTEXT
    Copes alleged that she was injured in a work related motor vehicle accident
    while she was driving a DART bus on January 23, 2021.1 After the accident, Copes
    was transported to the emergency room where she complained of left shoulder, neck,
    back, and leg pain.2 She was treated by several doctors, including two at First State
    Orthopedics - Dr. Lingenfelter (neck and low back) and Dr. Pushkarewicz (left
    shoulder).3 Copes’ shoulder care eventually transitioned from Dr. Pushkarewicz to
    Dr. Kahlon.4
    Copes filed a Petition to Determine Compensation Due (the “Petition”) for
    her injuries and a hearing was scheduled for June 29, 2021.5 The hearing did not
    take place because Copes withdrew the Petition on May 21, 2021.6 She refiled on
    September 8, 2021, and a new hearing was scheduled for January 5, 2022.7
    A week before that scheduled hearing, Copes and her counsel learned that she
    needed AC joint surgery.8 She requested a continuance to which DART agreed.9
    1
    Copes’ Op. Br. at 2, D.I. 13.
    2
    Id. at 4.
    3
    Id.
    4
    Id. at 4–5.
    5
    Id. at 2.
    6
    Id.
    7
    Id.
    8
    Id.
    9
    Id.
    2
    The hearing was rescheduled to March 7, 2022.10 After a follow up MRI was done
    on her left shoulder on January 25th, AC joint surgery was scheduled for April
    11th.11
    In light of the April 11th scheduled surgery, Copes asked for another
    continuance on February 25th, ten days before the rescheduled hearing on March
    7th.12 She argued that, since the surgery was scheduled for several weeks after the
    hearing, her surgeon, Dr. Kahlon, would not be able to provide a full picture of her
    injuries at the scheduled hearing date.13 A hearing was held on March 3, 2022 to
    address Copes’ continuance motion.14 DART opposed the continuance, pointing out
    that it had already expended a great deal of time and money in preparing for the
    hearing several times.15 Further, the IAB had enough before it to rule.16 DART did
    propose, however, that Copes could withdraw the Petition and refile once Dr. Kahlon
    supplied his opinion.17
    10
    Id.
    11
    Id. at 5.
    12
    Id.
    13
    Id. at 10.
    14
    Legal Hearing on Claimant’s Mot. for Continuance (“Tr. of March 3, 2022
    Hearing”), App’x. to Op. Br. at A000006–33, D.I. 13.
    15
    By this time, DART had incurred cancelled deposition fees for its medical expert
    in 2021 and would incur them for the March 7, 2022 hearing as well. IAB Order on
    Claimant’s Mot. for Continuance., App’x. to Op. Br. at A000034, D.I. 13.
    16
    Tr. of March 3, 2022 Hearing, App’x. to Op. Br. at A000014–15, D.I. 13.
    17
    Id. at A000015.
    3
    After considering the parties’ submissions, the IAB announced its denial of
    Copes’ motion to continue the hearing18 and issued a written decision shortly
    thereafter documenting the oral ruling.19     It found that Copes had adequate
    opportunity to review Dr. Kahlon’s advice from December 29, 2021, and that both
    parties had deposed their medical experts in preparation for a hearing on the
    petition.”20 It found that Copes “has not offered good cause and/or extraordinary
    circumstances” that would justify a continuance.21        In so finding, the IAB
    highlighted that while medical injuries evolve over time, “[t]his does not mean that
    a petition should be held open indefinitely for future treatment.”22 The IAB also
    reiterated that Copes could withdraw and re-file her Petition when she was prepared
    to proceed.23
    Despite being given the option of withdrawing and refiling her Petition, Copes
    elected to proceed with the March 7, 2022 IAB hearing without Dr. Kahlon’s
    testimony.24    During that hearing, the IAB heard from Copes,25 Copes’ spine
    18
    Id. at A000025.
    19
    IAB Order on Claimant’s Mot. for Continuance, App’x. to Op. Br. at A000034–
    37, D.I. 13.
    20
    Id. at A000036.
    21
    Id.
    22
    Id.
    23
    Id.
    24
    See Tr. of March 7, 2022 IAB Hearing on Petition to Determine Compensation
    Due (“March 7, 2022 IAB Hearing”), App’x. to Op. Br. at A000040–167, D.I. 13.
    25
    Id. at A000045:12–103:5.
    4
    physician, Dr. Lingenfelter (via deposition),26 and DART’s physician, Dr. Andrew
    Gelman.27 The IAB ultimately denied Copes’ Petition.28 This appeal followed.29
    III.   THE PARTIES’ CONTENTIONS
    The gravamen of Copes’ argument is that the IAB erred when it denied her
    request for a continuance because Dr. Kahlon was unable to testify about the full
    extent of her injuries as she had not yet had surgery.30 Copes argues that the denial
    was tantamount to denying her a full and fair hearing because she was “forc[ed]” to
    proceed without her surgeon’s testimony.31 She concedes that “nothing ‘capricious’
    appears about [the IAB’s] consideration,” but claims that its denial was
    unreasonable.32
    26
    Id., Deposition of Dr. Lingenfelter at A00168–A00233.
    27
    Id., Deposition of Dr. Gelman at A00234–A00300.
    28
    La’Tisha Copes v. Delaware Transit Authority, No. 1507923 (IAB Apr. 4, 2022),
    Record at Ex. 8, D.I. 8.
    29
    Notice of Appeal, D.I. 1.
    30
    Op. Br. at 9–11, D.I. 13.
    31
    Id. at 11.
    32
    Id. In her Reply Brief, Copes asks the Court to “affirm that ‘compensability of the
    shoulder surgery is a separate issue’ for which the claimant is still entitled to have a
    full and fair hearing, to include full consideration of Dr. Kahlon’s opinion.” (Reply
    Br. at 2, D.I. 15) The Court declines her request. In Copes’ own words the question
    presented to the Court is “[w]as the Board’s denial of Claimant’s February 25, 2022
    continuance motion ‘unreasonable or capricious,’ given that the opinion of her
    orthopedic surgeon regarding the AC joint injury could not be fully developed and
    presented until after her arthroscopic AC joint surgery scheduled for April 11,
    2022?” (Id. at 6). Since the issue of surgical compensability was not raised by Copes
    in her Opening Brief, the Court will not consider it.
    5
    DART responds that Copes was not forced to proceed with the hearing, and
    that the IAB informed her that she could withdraw her petition and refile it after her
    surgery.33 It also argues that the denial was appropriate because Copes failed to meet
    her burden of showing “good cause” sufficient to justify continuing the hearing.34
    Ultimately, DART claims that the IAB acted within its discretion and that its denial
    should be affirmed.35
    IV.    STANDARD OF REVIEW
    An IAB decision must be affirmed so long as “there is substantial evidence
    and no mistake of law.”36 Substantial evidence is “such relevant evidence as a
    reasonable mind might accept as adequate to support a conclusion.”37 In rendering
    its decision, the Court “[does] not weigh the evidence, determine questions of
    credibility, or make its own factual findings.”38 So, it must uphold the IAB’s
    decision unless it “exceeds the bounds of reason given the circumstances, or where
    33
    Ans. Br. at 1, 6–9, D.I. 14.
    34
    Id. at 10.
    35
    Id. at 10.
    36
    City of Newark v. Unemployment Ins. App. Bd. 
    802 A.2d 318
    , 323 (Del. Super. Ct.
    2002) (citing Avon Products, Inc. v. Wilson, 
    513 A.2d 1315
    , 1317 (Del. 1986));
    Conagra/Pilgrim’s Pride, Inc. v. Green, 
    954 A.2d 909
    , n 13 (Table) (Del. 2008).
    37
    Powell v. OTAC, Inc., 
    223 A.3d 864
    , 870 (Del. 2019) (quoting Ross Foods v.
    Guardado, 
    152 A.2d 114
    , 118 (Del. 2016)).
    38
    
    Id.
     (quoting Person-Gaines v. Pepco. Holdings, Inc., 
    981 A.2d 1159
    , 1161 (Del.
    2009)).
    6
    rules of law or practice have been ignored so as to produce injustice.”39 In reviewing
    an IAB decision, the Court must review the facts “in the light most favorable to the
    prevailing party below, resolving all doubts in its favor.”40
    When reviewing a discretionary ruling, such as the denial of a continuance
    request, the IAB’s decision “will not be set aside unless that decision is unreasonable
    or capricious.”41 The movant has the burden of proving that the IAB’s denial of a
    continuance request was “unreasonable or capricious.”42
    V.     DISCUSSION
    The IAB’s decision to grant or deny a continuance request is governed both
    by IAB Rule 12 (“Rule 12”) and 19 Del. C. §2348.        Pursuant to 19 Del. C. §2348,
    when considering a continuance request that would push the hearing “beyond 180
    days from the date of the petition, the party seeking the continuance must
    demonstrate that good cause for such an extension exists under a specific rule of the
    Industrial Accident Board and extraordinary circumstances exist which warrant the
    award of such continuance in the interests of justice.”43 There are exactly 180 days
    39
    Bromwell v. Chrysler LLC, 
    2010 WL 4513086
    , at *3 (Del. Super. Oct. 28, 2010)
    (quoting Bolden v. Kraft Foods, 
    889 A.2d 283
     (Table) (Del., 2005)). See also 29
    Del. C. § 10142(d).
    40
    Steppi v. Conti Elec., Inc., 
    991 A.2d 19
     (Del. 2010) (Table) (quoting General
    Motors Corp., v. Guy, 
    1991 WL 190491
    , at *3 (Del. Super. Ct., Aug. 16, 1991).
    41
    In re Kennedy, 
    472 A.2d 1317
    , 1331 (Del. 1984), cert. den., 
    467 U.S. 1205
     (1984)
    (citations omitted).
    42
    In re Kennedy, 
    472 A.2d at 1331
    .
    43
    19 Del. C. §2348(h)(2).
    7
    between September 8, 2021 (the date of re-filing) and March 7, 2022 (the scheduled
    hearing date). Granting the continuance request would have placed the hearing
    beyond the 180-day timeframe set forth in 19 Del. C. §2348(h), thus requiring Copes
    to demonstrate “good cause” and the existence of “extraordinary circumstances.”
    Rule 12(B)(1) defines “good cause” to include:
    (a) the unavailability of a previously scheduled medical or other material
    witness;
    (b) the unavailability of an attorney for a party due to a conflicting court
    appearance;
    (c) the illness of a party, a party’s attorney or a material witness (including, if
    appropriate, illness which affects the ability of necessary persons to
    participate in the deposition of a medical or other material witness);
    (d) a justifiable absence from the State of a party, a party's attorney or material
    witness;
    (e) a justifiable substitution of counsel for one party (this shall not include a
    transfer of files within a law firm);
    (f) the unavailability of a medical witness whose deposition cannot be
    scheduled despite due and prompt diligence on the part of the requesting party;
    (g) inadequate notice from the Department and/or the Board which would
    justifiably prevent a party from having a full and fair opportunity to be heard;
    and
    (h) any other unforeseen circumstances beyond the control of the party
    seeking the continuance which would prevent the party from having a full and
    fair hearing.44
    Rule 12(B)(2) defines “extraordinary circumstances” to include:
    (a) the sudden unavailability of a previously scheduled medical or other
    material witness;
    (b) an emergency mandatory court appearance which precludes the
    appearance of a party’s attorney at the hearing;
    (c) a serious personal or medical emergency on the part of a party or a party’s
    attorney; and
    44
    IAB Rule 12(B)(1).
    8
    (d) any other unforeseen circumstance beyond the control of the party seeking
    the continuance which would prevent the party from having a full and fair
    hearing.45
    In considering Copes’ request, the IAB considered the financial and timing
    consequences of a continuance (i.e., re-deposing experts and DART’s already-
    accrued cancellation fees),46 the fact that Copes had “adequate opportunity” to
    prepare,47 and that the evolving nature of personal injury cases is not a carte blanche
    to have cases “held open indefinitely for future treatment.”48            The IAB also
    highlighted that Copes “is free to withdraw the petition and re-file it at a later date.”49
    The Court finds that the IAB’s decision to deny Copes’ continuance request
    on those grounds was not unreasonable or capricious. It was Copes’ decision that
    resulted in the hearing being held when it was. She could have accepted the IAB’s
    suggestion that she withdraw her petition and refile it after her surgery. Instead, she
    chose to proceed on the basis of her own testimony and that of Dr. Lingenfelter, both
    of which the IAB found unpersuasive.50 Having received an unfavorable ruling from
    the IAB, she cannot now revisit her decision to go forward with the hearing.
    45
    IAB Rule 12(B)(2).
    46
    IAB Order on Claimant’s Mot. for Continuance, App’x. to Op. Br. at A000035–
    36, D.I. 13.
    47
    Id. at A000036.
    48
    Id.
    49
    Id.
    50
    Ans. Br. at 3–4, D.I. 14.
    9
    DART correctly points out that Copes was requesting a continuance in the
    expectation that Dr. Kahlon would be able to provide a helpful post-surgical
    opinion.51 However, whether that expectation is realized is merely “speculative”
    and does not establish grounds for a remand.52 In fact, this Court has already found
    to the contrary - that, as here, claimants’ failure to secure their own treating
    physicians’ opinions on causation does not constitute “good cause” under 19 Del.
    C. §2348(h) or Board Rule 12.53
    After considering the totality of circumstances presented to it, the IAB found
    that “[Copes] has not offered good cause and/or extraordinary circumstances for
    further delaying a hearing on the issue of initial compensability in this case.”54
    Based on the record before it, the Court agrees.
    VI.   CONCLUSION
    For the foregoing reasons, the Industrial Accident Board’s decision is
    AFFIRMED.
    IT IS SO ORDERED.
    /s/ Ferris W. Wharton
    Ferris W. Wharton, J.
    51
    Id. at 8.
    52
    Id.
    53
    Id. at 6–7 citing Harris v. Citigroup Global Mark, 
    2021 WL 5013825
     (Del. Super.
    Ct. Oct. 28, 2021).
    54
    
    Id.
    10